This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Beatriz Noya Marino: Innovator in Kinase Inhibitors
Introduction
Beatriz Noya Marino is a notable inventor from Spain, recognized for her contributions to the field of medicinal chemistry. Her work primarily focuses on the development of tricyclic compounds that serve as kinase inhibitors, which are crucial in the treatment of various diseases, including cancer.
Latest Patents
Although Beatriz Noya Marino currently holds no patents, her significant work includes the invention of tricyclic compounds for use as kinase inhibitors. These compounds are designed to inhibit specific protein or lipid kinases, such as PIM family kinases, which play a vital role in the progression of cancer and other proliferative diseases.
Career Highlights
Throughout her career, Beatriz has made substantial contributions to the understanding and development of therapeutic agents targeting kinase pathways. Her innovative approach to drug design has positioned her as a key figure in the pharmaceutical research community.
Collaborations
Beatriz has collaborated with esteemed colleagues, including Joaquin Pastor Fernandez and Carmen Blanco Aparicio, to advance her research and enhance the efficacy of her inventions.
Conclusion
Beatriz Noya Marino's work in developing kinase inhibitors represents a significant advancement in cancer treatment. Her innovative contributions continue to inspire future research in the field of medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile